Intermediate Risk Prostate Cancer May Be Safely Controlled with Brachytherapy Alone

Intermediate Risk Prostate Cancer May Be Safely Controlled with Brachytherapy Alone
Patients with prostate cancer who receive brachytherapy alone have similar cancer control rates and fewer side effects compared to those who receive brachytherapy in combination with external beam therapy (EBT), according to the results of a Phase 3 clinical trial. The abstract, “Initial Report of NRG Oncology/RTOG 0232: A Phase III Study Comparing Combined External Beam

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *